iShares NASDAQ Biotechnology Index (ETF) (NASDAQ:IBB)
| CAPS Rating |
|
|---|---|
| Open | $118.71 |
| Previous Close | $119.44 |
| Daily Range | $118.19 - $119.17 |
| 52-Week Range | $83.96 - $122.45 |
| Market Cap | $1.61B |
| P/E Ratio | 0.00 |
| Dividend (Yield) | 0.01 (1.00%) |
| Volume | 514,432 |
| Average Daily Volume | 0 |
IBB
VS S&P 500 (SPY)
How do you think IBB will perform against the market?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
IBB Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
IBB News and Commentary
- ETF Fund Flows: SPY Nets $1.16 Billion – NASDAQ
- 5-Star ETFs Poised to Pop: SPDR S&P Biotech – The Motley Fool
- 5-Star ETFs Poised to Pop: iShares S&P Global Healthcare – The Motley Fool
- 5-Star ETFs Poised to Pop: iShares Nasdaq Biotechnology – The Motley Fool
- Data Published; Back to Waiting – The Motley Fool
- How Dendreon Can Fix Its Broken Relationship With Wall Street – Minyanville
- As Cisco Sputters, Other Nasdaq Hits From '90s Return – SmartMoney
- Short-Term, High-Probability Mean-Reversion Indicator: FXI and EPI Very Oversold – SeekingAlpha
- Use Options to Create a Diversified Cancer Therapeutics Portfolio – SeekingAlpha
- High-Probability, Mean-Reversion Strategy - Options Strategy Continues to Succeed – SeekingAlpha
- Growth in U.S. Drug Sales Slows – SeekingAlpha
- Short-Term, High-Probability Mean-Reversion Indicator: TBT Moves Into an Extreme State – SeekingAlpha
- Four ETFs to Play an Aging Population – SeekingAlpha
- The Search for Undervalued Sector ETFs – SeekingAlpha
- Why Phase II Trials Are the Best Time for Biotech Investing – SeekingAlpha
- Short-Term, High-Probability, Mean-Reversion Strategy: Outperforming – SeekingAlpha
- Surprisingly Healthy Returns From Healthcare ETFs – SeekingAlpha
- Short-Term, High-Probability Mean-Reversion Strategy: Adding SLV – SeekingAlpha
- Time to Consider Xenoport Among Biotech Strategies for Your Portfolio – SeekingAlpha
- Short-Term, High-Probability Mean-Reversion Strategy: SPY Still Trading in a Tight Range Bound Fashi – SeekingAlpha
RSS Headlines
Fool UK
